134 related articles for article (PubMed ID: 4987199)
1. Persistence of an Escherichia coli-Shigella flexneri hybrid in the intestinal tract of Macaca mulatta.
Wynne ES; Henrikson DM; Daye GT
Appl Microbiol; 1970 May; 19(5):731-3. PubMed ID: 4987199
[TBL] [Abstract][Full Text] [Related]
2. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.
Formal SB; Hale TL; Kapfer C; Cogan JP; Snoy PJ; Chung R; Wingfield ME; Elisberg BL; Baron LS
Infect Immun; 1984 Nov; 46(2):465-9. PubMed ID: 6389344
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization of monkeys with polyvalent dysentery vaccine.
Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
[TBL] [Abstract][Full Text] [Related]
4. Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine.
Formal SB; Kent TH; May HC; Palmer A; Falkow S; LaBrec EH
J Bacteriol; 1966 Jul; 92(1):17-22. PubMed ID: 4957431
[TBL] [Abstract][Full Text] [Related]
5. Observations on shigellosis and development of multiply resistant Shigellas in Macaca mulatta.
Lindsey JR; Hardy PH; Baker HJ; Melby EC
Lab Anim Sci; 1971 Dec; 21(6):832-44. PubMed ID: 4332152
[No Abstract] [Full Text] [Related]
6. ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN.
FORMAL SB; LABREC EH; KENT TH; FALKOW S
J Bacteriol; 1965 May; 89(5):1374-82. PubMed ID: 14293011
[TBL] [Abstract][Full Text] [Related]
7. Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.
Kotloff KL; Herrington DA; Hale TL; Newland JW; Van De Verg L; Cogan JP; Snoy PJ; Sadoff JC; Formal SB; Levine MM
Infect Immun; 1992 Jun; 60(6):2218-24. PubMed ID: 1587589
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
[TBL] [Abstract][Full Text] [Related]
9. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
Kärnell A; Cam PD; Verma N; Lindberg AA
Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
[TBL] [Abstract][Full Text] [Related]
10. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
Kärnell A; Sweiha H; Lindberg AA
Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella flexneri.
Formal SB; Kent TH; Austin S; Labrec EH
J Bacteriol; 1966 Jun; 91(6):2368-76. PubMed ID: 4957617
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
[TBL] [Abstract][Full Text] [Related]
13. Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri.
Levine MM; Woodward WE; Formal SB; Gemski P; DuPont HL; Hornick RB; Snyder MJ
J Infect Dis; 1977 Oct; 136(4):577-82. PubMed ID: 333041
[TBL] [Abstract][Full Text] [Related]
14. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
[No Abstract] [Full Text] [Related]
15. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri].
Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK
Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775
[No Abstract] [Full Text] [Related]
16. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
Sagi S; Konduru B; Parida M
Int Immunopharmacol; 2020 Aug; 85():106617. PubMed ID: 32464569
[TBL] [Abstract][Full Text] [Related]
17. Shigellosis in cynomolgus monkeys (Macaca irua). VI. The inoculation with various doses of Shigella flexneri 2a into cecal lumen.
Takasaka M; Honjo S; Fujiwara T; Imaizumi K; Ogawa H
Jpn J Med Sci Biol; 1968 Aug; 21(4):275-81. PubMed ID: 4974847
[No Abstract] [Full Text] [Related]
18. Bacillary dysentery in cynomolgus monkeys following the administration with Shigella flexneri 2A by the anal route.
Takasaka M; Honjo S; Cho F; Imaizumi K; Ogawa H
Jpn J Med Sci Biol; 1971 Dec; 24(6):379-85. PubMed ID: 5003951
[No Abstract] [Full Text] [Related]
19. Incidence of Shigella in conditioned rhesus monkeys (Macaca mulatta).
Weil JD; Ward MK; Spertzel RO
Lab Anim Sci; 1971 Jun; 21(3):434-7. PubMed ID: 4329311
[No Abstract] [Full Text] [Related]
20. Development of an auxotrophic oral live Shigella flexneri vaccine.
Lindberg AA; Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP
Vaccine; 1988 Apr; 6(2):146-50. PubMed ID: 2838986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
